Background {#Sec1}
==========

Nutritional status is a closely tied to immune responses to infection, being on the one hand, an important determinant of the risk and prognosis of infectious diseases, and on the other hand, being directly influenced by infection \[[@CR1]\]. This bi-directional pattern of synergistic interaction in which, a worse nutritional status negatively contributes to the development and evolution of infections, whereas infections lead to a worsening of nutritional status, is a crucial phenomenon for the understanding of infections' population dynamics and to establish control strategies for these diseases \[[@CR2], [@CR3]\].

Malaria is a preventable, diagnosable and treatable disease. With recent innovations and roll out of multinational interventions, there are fewer people dying from malaria today than 10 years ago. Nonetheless, malaria is still a deadly disease with approximately 219 million cases and 660,000 deaths in 2013 \[[@CR4]\]. Malnutrition is also a major public health problem in tropical areas where malaria prevails, with estimated 38 % stunted, 28 % underweight, and 9 % wasted in Africa \[[@CR5]\]. To date, findings from studies evaluating associations between various measures of malnutrition and malaria have been contradictory.

Nutritional status impacts on mortality among children under 5 years due to diarrhoea, respiratory diseases, malaria and measles \[[@CR6]\]. In relation to morbidity, a big part of the studies found that children and adolescents with chronic malnutrition (stunting) and low weight for age (underweight) besides thin adult have protection against prevalent cerebral malaria \[[@CR7]--[@CR10]\], stunted and underweight children and adolescents have less prevalence and incidence of hyperparasitaemia \[[@CR11]--[@CR16]\] and, to a lower extent, children and adolescents with wasting or stunting were protected against new episodes of clinical malaria \[[@CR17], [@CR18]\]. Although limited by the small number of studies, malnutrition may contribute to deaths from malaria, even though the significance was not high compared with other diseases \[[@CR2], [@CR7], [@CR18]--[@CR20]\]. In contrast, some studies found no association between nutrition and subsequent mortality from malaria \[[@CR21], [@CR22]\].

Although several studies in various parts of the world analysed the impact of nutritional status on malaria using anthropometric measures, their results differ due to the heterogeneity of the study population, species of the parasite, and other factors involved in host and parasite relationship. The aim of this study was to perform a systematic review on the evidence for relationship between malaria and subsequent chronic or acute malnutrition based on anthropometry, for the protective effect of malnutrition on malaria outcomes, and for malnutrition increasing the risk of adverse malaria outcomes.

Methods {#Sec2}
=======

Search strategy {#Sec3}
---------------

A systematic review was performed in order to identify the available published data on malaria and malnutrition causal interactions. A broad free text search was made using the terms (malaria OR plasmodium) AND \[(anthropometry) OR (anthropometric) OR (nutrition)) for PUBMED and (malaria OR plasmodium) AND (anthropometry) OR (anthropometric) OR (nutri\$)\] for LILACS. Potentially relevant papers in all languages were accessed from MEDLINE (September 2014) and LILACS (September 2014) in order to review full texts. Additional articles were obtained through citation tracking of reviews/opinion articles and original papers. The titles, abstracts, and studies identified in the literature search were assessed by two reviewers. All studies matching the inclusion criteria were reviewed by the authors and disagreement in conclusion was settled through discussion. Articles written in English, Portuguese, Spanish, German and French were included.

Inclusion criteria, exposures and outcomes {#Sec4}
------------------------------------------

For this study, observational studies in non-pregnant populations and without co-morbidities (co-infections, genetic or metabolic and other chronic diseases) were included. Studies on any of the *Plasmodium* species were included. Only original prospective cohort studies were included, presenting one of the following characteristics of exposure and outcome:Malnutrition assessed by anthropometric measurements as the independent variable and morbidity or mortality from malaria as the outcome.Malaria as an exposure variable and malnutrition assessed by anthropometric measurements as the outcome.

The anthropometric variables gathered in the articles were anthropometric indices \[(height/age (H/A), weight/height (W/H), weight/age (W/A), arm circumference/age (AC/A), body mass index (BMI)\], measures of skinfold thicknesses, body circumferences and increments in weight, height or anthropometric measures throughout follow-up. As malarial variables, we looked for frequencies of malaria such as incidence or prevalence, parasitaemia, complications and mortality as outcomes. Severity criteria recommended by the World Health Organization (anaemia, cerebral malaria, hypoglycaemia, renal failure, pulmonary oedema, or acute respiratory distress syndrome, circulatory collapse, abnormal bleeding or disseminated intravascular coagulation, haemoglobinuria, seizures, acidosis, hyperbilirubinaemia, hyperpyrexia and prostration) were used \[[@CR23]\].

Data extraction {#Sec5}
---------------

One independent reviewer (EDF) supervised by a senior reviewer (MAA) extracted the relevant data using a predesigned data extraction form. Disagreements between the two reviewers were resolved by referring to a third reviewer (WMM). Information for article identification, exposure variables and outcome measurement, sample size, age group, level of malaria transmission in the study site, follow-up time, species of *Plasmodium* spp., confounders adjusted in the analysis and type of association were extracted. Data on the type of association (statistical comparison) between the exposure and the outcome were retrieved. The association was classified as neutral when the exposure had no impact on the outcome, as risk when the exposure increased the outcome and as protection when the exposure decreased the outcome.

Evidence quality evaluation {#Sec6}
---------------------------

To assess the quality of the included studies, an adapted questionnaire originated from the *Check List for Measuring Quality* proposed by Downs and Black was applied \[[@CR24]\]. The validity of the studies was determined by scores received after the evaluation of 12 questions, according to Table [1](#Tab1){ref-type="table"}. For each question with an affirmative answer, 1 point was assigned to the study. Negative or inconclusive responses did not lead to scoring. Studies with scores \>70 % were considered of high quality, while studies with scores 50--69.9 % were considered of intermediate quality score and below 50 % classified as low quality.Table 1Questions used for evidence quality evaluation in the systematic reviewOrderQuestion1The study clearly describes its objectives and hypotheses?2The study clearly describes the exposures and outcomes?3The study describes basic characteristics of participants (age and gender)?4The results of the statistical analysis were presented explicitly (p values and/or confidence intervals)?5The study provided estimates of random variability in the results of the main outcome measures (standard deviation, standard error, confidence interval)?6The results were adjusted for possible confounding variables through stratification or multivariate analysis?7The study informs the loss characteristics (numbers and reasons)?8Participants were followed for the same time or the study was adjusted for different follow-up times?9Statistical tests used were adequate (non application of parametric statistics for population under 100)?10The measures used for the main outcomes were accurate (description of the technique for the diagnosis of malaria and nutritional status)?11The demographic characteristics of the groups were comparable or adjusted (age and geographic area)?12The participants of different groups were recruited in the same period of time?

Results {#Sec7}
=======

Selection and general characteristics of the study {#Sec8}
--------------------------------------------------

The search identified a total of 1688 studies: 1629 from MEDLINE and 59 from LILACS. After screening titles and abstracts, 950 publications were excluded due to a lack of information regarding an association between malaria and malnutrition, not being original articles or being duplicates, reviews, reports, case--control, ecological or cross-sectional studies, unavailable articles and presence of co-morbidities in participants (Fig. [1](#Fig1){ref-type="fig"}). After reading the remaining 738 full articles, 598 more publications were excluded for similar reasons. A total of 139 studies were taken to a consensus meeting, where 116 did not meet the inclusion criteria. References of the 23 included articles were reviewed, giving 5 extra articles, totaling 28 items for systematic review published from 1977 to 2014.Fig. 1Flow chart of study selection

Twenty-three (82.1 %) studies were conducted in Africa, three (10.7 %) in Oceania (two of Papua New Guinea and Vanuatu), one (3.5 %) in Asia (Vietnam) and one (3.5 %) in South-America (Brazil). African countries with the largest number of studies were Gambia (4), Congo (3) and Ghana (3). Of the 28 included studies, one was done in the 70 s, one in the 80 s, ten in the 90 s, nine in the 2000s and seven in the decade of 2010. Among the 28 included studies, 20 presented anthropometric variables as exposure and had malaria as the outcome, while 13 had malaria as the exposure and malnutrition as the outcome. Five studies conducted evaluations in both directions and were included in both analyses.

Eleven studies did not report the agent responsible for malaria, all from Africa where *P. falciparum* prevails. Fourteen studies had participants with *falciparum* malaria, one with *falciparum* and *vivax*, one with *falciparum*, *malariae* and *vivax* and one with *vivax*/*falciparum* malaria. The setting was characterized as hyperendemic in nine studies, as holoendemic in two, endemic in four, hypoendemic in two, mesoendemic in one and endemicity was not reported in 10 studies. The mean sample size was 662.1 people, ranging from 57 to 5620. The mean follow-up was 365.8 days, ranging from 14 days to 1 year and 9 months, and nine studies did not report the follow-up period. The characteristics and results of these studies are shown in Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}.Table 2Summary of the results from longitudinal studies with anthropometric measures as exposures and malaria-related outcomesIdentificationCountryAge group/follow-up time*Plasmodium* speciesSample sizeExposure (undernutrition)OutcomeEffect measure/intensityResultCovariates tested or adjustedPazzaglia et al. \[[@CR28]\]VietnamFollow-up of 28 days*P. falciparum*Grams/dayMultiple regressionAge, race, total duration of infection, duration of primary attack, pre-patent period, incubation period, peak of fever58Increment on weightTime to peak parasite densityNI (p = 0.050)Protection42Increment on weightTime to peak gametocytaemiaNI (p = 0.050)RiskSnow et al. \[[@CR29]\]Gambia1 to 4 years (Follow-up of 4 months)*P. falciparum*Z-score (mean with SD) (NCHS, 1977)"t" Test (mean z-score at baseline anthropometry)None138H/AIncidence (clinical malaria *vs* no malaria)−0.96 *vs* −0.89No association138W/HIncidence (clinical malaria *vs* no malaria)−1.03 *vs* −1.18No association138W/AIncidence (clinical malaria *vs* no malaria)−1.39 *vs* −1.47No association34H/AIncidence (asymptomatic malaria vs no malaria)−0.97 *vs* −0.89No association34W/HIncidence (asymptomatic malaria vs no malaria)−0.96 *vs* −1.18No association34W/AIncidence (asymptomatic malaria vs no malaria)−1.35 *vs* −1.47No association59H/AHigh parasite density in clinical malaria (≥5000/µL)−1.03 *vs* −0.94No association59W/HHigh parasite density in clinical malaria (≥5000/µL)−1.32 *vs* −0.91No association59W/AHigh parasite density in clinical malaria (≥5000/µL)−1.67 *vs* −1.28No association15H/AHigh parasite density on asymptomatic infection (≥5000/µL)−1.84 *vs* −0.81No association15W/HHigh parasite density on asymptomatic infection (≥5000/µL)−0.89 *vs* −1.06No association15W/AHigh parasite density on asymptomatic infection (≥5000/µL)−1.34 *vs* −1.36No associationVan den Broeck et al. \[[@CR21]\]Congo\<5 years*P. falciparum*Z-score (\<−2) (NCHS, 1977)RRNone64H/AMortality (3 months follow up)NI (NS)No association64W/HMortality (3 months follow up)NI (NS)No association64W/AMortality (3 months follow up)NI (NS)No association64AC/AMortality (3 months follow up)NI (NS)No association64H/AMortality (3--30 months follow up)NI (NS)No association64W/HMortality (3--30 months follow up)NI (NS)No association64W/AMortality (3--30 months follow up)NI (NS)No association64AC/AMortality (3--30 months follow up)NI (NS)No associationGenton et al. \[[@CR22]\]Papua New Guinea11 months to 11 years*P. falciparum*Z-score (\<−2) (NCHS, 1977)ORAge, duration of symptoms, temperature, pulse rate, respiratory rate, parasite density, glycaemia, haemoglobin, maematocri, white cell count121W/AMortality (cerebral malaria)0.98 (0.65--1.49)No associationOlumese et al. \[[@CR7]\]Nigeria1 to 5 years*P. falciparum*Percentile ≤80 % (NCHS, 1977)Fisher's exact testNone57W/ADeath or recover with neurological deficit on cerebral malariaNI (p = 0.037)RiskRenaudin et al. \[[@CR20]\]Chad\<5 years*P. falciparum*Z-score (\<−2) (NCHS, 1977)X^2^ (Chi-square)None227W/HMortalityNI (NS)No associationWilliams et al. \[[@CR30]\]Vanuatu\<10 years*P. falciparum*/*P*. *vivax*Z-score (\<−2) (NCHS, 1977)RRNone702W/HIncidence (*P. falciparum*NI (NS)No association702W/AIncidence (*P. falciparum*1.1 (0.57--2.1)No association702W/HIncidence (*P.vivax* **)**NI (NS)No association702W/AIncidence (*P.vivax* **)**2.6 (1.5--4.4)RiskMan et al. \[[@CR2]\]Gambia\<5 years*P. falciparum*Z-score (\<−2) (NCHS, 1977)RRNone5,620W/AMortalityNI (S)Risk1,292W/ACerebral malariaNI (S)Risk1,473W/AMalarial anaemiaNI (S)RiskGenton et al. \[[@CR16]\]Papua New Guinea10 months to 10 years*P. falciparum*/ *vivax*/*malariae*Z-score (\<−2) (NCHS, 1977)RRAge, bednet use136H/AIncidence (*P.* spp.)1.1 (0.97--1.24)No association136W/HIncidence (*P.* spp.)0.95 (0.81--1.11)No association136H/AIncidence (*P. falciparum* **)**1.13 (0.98--1.29)No association136W/HIncidence (*P. falciparum*)0.92 (0.77--1.11)No association136H/AHigh parasite density (*P. falciparum*≥5,000/µL)1.19 (1.01--1.40)Protection136W/HHigh parasite density (*P. falciparum*≥5,000/µL)0.96 (0.77--1.19)No association136H/AHigh parasite density (*P. falciparum*≥10,000/µL)1.18 (0.98--1.41)No association136W/HHigh parasite density (*P. falciparum*≥10,000/µL)0.97 (0.75--1.24)No association136H/AIncidence (*P. vivax*)0.96 (0.73--1.25)No association136W/HIncidence (*P. vivax*)0.95 (0.70--1.28)No association136H/AIncidence (*P.malariae*)0.83 (0.44--1.57)No association136W/HIncidence (*P.malariae*)0.90 (0.49--1.63)No associationSchellenberg et al. \[[@CR31]\]Tanzania\<4 years (Follow-up of 1 year)*P. falciparum*Percentile ≤25 (NCHS, 1977)ORNone651W/A (1-7 months)Mortality3.2 (1.2--8.9)Risk1,620W/A (8 months--4 years)Mortality3 (1.5--6.2)RiskPercentile \>25--50 (NCHS, 1977)651W/A (1--7 months)Mortality2.6 (1--6.9)No association651W/A (8 months--4 years)Mortality1.9 (0.8--4.2)No associationTonglet et al. \[[@CR32]\]Congo\<2 years (Follow-up of 3 months)*P. falciparum*842Median \<25 (NCHS, 1977) \<9 monthsORAge, gender, time of enrolment, malaria during preceding month, diet, adequate growth as judged by care-taker842H/AIncidence1.16 (0.54--1.77)No association842H/A incrementIncidence1.53 (0.95--2.11)No association842W/AIncidence1.31 (0.68--1.94)No association842W/A incrementIncidence1.05 (0.40--1.69)No association842AC/AIncidence2.32 (1.68--2.97)Risk842AC/A incrementIncidence0.98 (0.35--1.60)No associationMedian \<25 (NCHS, 1977) ≥9 months842H/AIncidence0.71 (0.28--1.14)No association842H/A incrementIncidence0.74 (0.31--1.16)No association842W/AIncidence0.68 (0.24--1.11)No association842W/A incrementIncidence0.70 (0.28--1.13)No association842AC/AIncidence0.97 (0.54--1.40)No association842AC/A incrementIncidence1.10 (0.68--1.51)No associationDeen et al. \[[@CR33]\]Gambia\<5 years (Follow-up of 20 weeks)*P. falciparum*Z-score (\<−2) (NCHS, 1977)RRAge, gender, ethnicity487H/AIncidence1.35 (1.08--1.69)Risk487W/HIncidence0.87 (0.69--1.10)No association487W/AIncidence1.01 (0.82--1.26)No associationMuller et al. \[[@CR34]\]Burkina Faso6 to 30 months (Follow-up of 6 months)*P. falciparum*Z-score (≤−2) (NCHS, 1977)RRAge, gender, bednet use, socioeconomic status, ethnicity685H/AIncidence1 (0.9--1.1)No association685W/HIncidence1 (0.9--1.1)No association685W/AIncidence1 (0.9--1.2)No association685H/AHigh parasite density (≥5,000/µL)1 (0.9--1.2)No association685W/HHigh parasite density (≥5,000/µL)1 (0.9--1.2)No association685W/AHigh parasite density (≥5,000/µL)1 (0.9--1.2)No association685H/AHigh parasite density (≥10,000/µL)0.8 (0.5--1.4)No association685W/HHigh parasite density (≥10,000/µL)0.8 (0.5--1.4)No association685W/AHigh parasite density (≥10,000/µL)1 (0.5--1.8)No associationMockenhaupt et al. \[[@CR35]\]Ghana6 months to 9 years*P. falciparum*Z-score (\<−2) (NCHS, 1977)ORAge, gender, shock, respiratory distress, haemoglobinuria, multiple convulsions, severe anemia, jaundice, prostration, cerebral malaria, impaired consciousness, hyperlactataemia hyperparasitaemia hypoglycaemia, hyperpyrexia285W/HMortality (severe malaria)2.8 (1.1--7.0)RiskNyakeriga et al. \[[@CR36]\]Kenia28 to 60 months (Follow-up of 1 year and 5 months)*P. falciparum*Z-score (\<−2) (NCHS, 1977)IncidenceRRAge, ethnicity, season, haemoglobin genotype341H/AIncidence1.09 (0.92--1.28)No association341W/AIncidence0.96 (0.78--1.19)No associationDanquah et al. \[[@CR37]\]Ghana3 months to 2 years (Follow-up of 1 year and 9 months)*P. falciparum*Z-score (≤−2) (WHO, 2006)RRSeason, food availability1,200H/A, L/A, W/H and W/A combined indexIncidence (non-severe malaria)NI (NS)No association1,200H/A, L/A, W/H and W/A combined indexIncidence (assymptomatic malaria)NI (NS)No associationFillol et al. \[[@CR17]\]Senegal12 to 70 months (Follow-up of 25 weeks)*P. falciparum*Z-score (\<−2) (WHO, 2006)ORAge, gender, site of residence, presumptive antimalarial treatment874H/AIncidenceNI (NS)No association874W/HIncidence0.33 (0.13--0.81)Protection874W/AIncidenceNI (NS)No association874H/AHigh parasite density (\>300 parasites/µL)2.42 (1.12--5.24)Risk874W/HHigh parasite density (\>300 parasites/µL)0.48 (0.04--5.34)No association874W/AHigh parasite density (\>300 parasites/µL)0.55 (0.35--2.66)No associationArinaitwe et al. \[[@CR38]\]Uganda6 weeks to 1 year (Follow-up of 1 year and 4 months)*P. falciparum*Z-score (\<−2) (WHO, 2006)RRAge, site of residence, chemoprophylaxis, breastfeeding, HIV status99H/AIncidence1.24 (1.03--1.48)Risk99W/AIncidence1.12 (0.86--1.46)No associationMitangala et al. \[[@CR15]\]Congo6 to 59 months (Follow-up of 1 year)*P. falciparum* (99 %)/*malariae*/mixed malaria (*P. falciparum* + *P. ovale*)Z-score (\<−3) (WHO, 2006)ORAge, season790H/AIncidence1.21 (0.76--1.92)No association790W/HIncidence1.46 (0.84--2.53)No association790W/AIncidence1.13 (0.82--1.55)No association790ACIncidence1.14 (0.71--1.83)No association787H/AIncidence (high parasite density -≥5000/µL)0.48 (0.25--0.91)Protection787W/HIncidence (high parasite density -≥5000/µL)0.87 (0.38--1.99)No association787W/AIncidence (high parasite density -≥5000/µL)0.85 (0.53--1.35)No association787ACIncidence (high parasite density -≥5000/µL)0.83 (0.44--1.55)No associationAlexandre et al. \[[@CR39]\]Brazil1 month to 14 years (Follow-up of 12 months)*P. vivax* (72.6 %)/*P. falciparum*(22.5 %)/Mixed malaria *P. vivax* + *P. falciparum*(4.9 %)Z-score (\<−2) (WHO, 2006; WHO, 2007)HRAge, gender, maternal education, socioeconomic status202H/AIncidence0.31 (0.10--0.99)Protection*BMI* body mass index, *H/A* height/age, *W/H* weight/height, *W/A* weight/age, *AC/A* arm circumference/age, *L/A* length/age, *SD* standard-deviation, *NS* non-significant, *NI* non-informedTable 3Summary of the results from longitudinal studies with malaria patients and nutritional-related outcomesIdentificationCountry**Age group/follow-up time***Plasmodium* speciesSample sizeExposureOutcomeEffect measure/statistic and CIResultCovariates tested or adjustedRowland et al. \[[@CR40]\]Gambia6 months to 3 years (Follow-up of 1 year)*P. falciparum*RegressionNone152IncidenceIncrement on weight1.072 (268) (*p* = \<0.001)Risk152IncidenceIncrement on weight7.0 (6.0) (NS)No associationWilliams et al. \[[@CR30]\]Vanuatu\<10 years*P. falciparum*/*vivax*Z-score (\<−2) (NCHS, 1977)IRR (Incidence rate ratio)None911Incidence (*P. falciparum*)W/HNI (NS)No association911Incidence (*P. falciparum*)W/A1.3 (0.9--1.9)No association911Incidence (*P. vivax*)W/H2.2 (1--4.9)Risk911Incidence (*P. vivax*)W/A1.3 (0.9--2.0)No associationHautvast et al. \[[@CR41]\]Zambia6 months to 3 years and 4 months (Follow-up of 1 year and 9 months)*P. falciparum* (94 %)/Mixed malaria(19 %)Parasite density (mean with SD)Z-score (mean with SD)*r* (Pearson's)Age, gender, socioeconomic status, maternal height, haemoglobin, albumin, zinc, retinol, thyrotropin, iron, ferritin, parasite density, C-reative protein, alfa-acid glycoprotein108Cohort 1 Parasite density on period 1 (age range of 6--9 months) *vs Z*-score on period 2 (age range of 14--20 months)H/A−0.30 (*p* = 0.005)Risk102Cohort 2 Parasite density on period 2 (age range of 14--20 months) *vs Z*-score on period 3 (age range of 22--30 months)H/A−0.28 (*p* = 0.03)RiskDeen et al. \[[@CR33]\]Gambia\<5 years (Follow-up of 20 weeks)*P. falciparum*Z-score (\<−2) (NCHS, 1977)"t" TestAge, gender, ethnicity392IncidenceH/ANI (NS)No association392IncidenceW/HNI (NS)No association392IncidenceW/ANI (NS)No associationFriedman et al. \[[@CR42]\]Kenia12 to 35 years*P. falciparum*Parasite density (mean with SD)Z-score (mean with SD) (CDC/NCHS, 2000)B (Pearson's)Age, parasite density, peripheral blood mononuclear cell production of TNF-alfa in response to mitogen or malarial antigens147Whole cohort Parasite density in the previous transmission period *vs* Z-score and Kg/m^2^BMI/Age−0.201 (*p* = 0.11)No association83Tanner stage \<3 (prepubescent) Parasite density in the previous transmission period *vs* Z-scoreKg/m^**2**^ BMI (mean with SD) \<17 kg/m^2^ (≥20 years)−0.324 (*p* = 0.02)Risk83Tanner stage ≥3 (adult) Parasite density in the previous transmission period *vs* Kg/m^2^BMI (mean with SD) \<17 kg/m^2^ (≥20 years)0.16 (*p *= 0.51)No associationNyakeriga et al. \[[@CR36]\]Kenia28 to 60 months (Follow-up of 1 year and 5 months)*P. falciparum*Z-score (\<−2) (NCHS, 1977)RRRiskAge, ethnicity, season, haemoglobin genotype340IncidenceH/A1.89 (1.01--3.53)Risk340IncidenceW/A1.33 (0.64--2.70)No associationSowumi et al. \[[@CR43]\]Nigeria\<13 years (Follow-up of 14 days)*P. falciparum*Fall in weightORAge, gender, fever, duration of illness, parasitaemia, haematocrit, liver and spleen enlargement432Parasite density(≥100,000/µl parasites)≤5 % from admission to d141.21 (0.72--2.01)No associationDanquah et al. \[[@CR37]\]Ghana3 months to 2 years (Follow-up of 1 year and 9 months)*P. falciparum*Z-score (≤−2) (WHO, 2006)GEE (General estimating equation)Season, food availability1200IncidenceH/A or L/A−0.18 (*p *= 0.01)Risk1200IncidenceW/HNI (NS)No association1200IncidenceW/ANI (NS)No associationKang et al. \[[@CR44]\]Ghana3 months to 2 years (Follow-up of 1 year and 9 months)*P. falciparum*Z-score (\<−2) (WHO, 2006)RRGender, birth weight, birth season, ethnicity group, alpha-thalassaemia, village of birth, mother's occupation, mother's education, family's financial status, mosquito protection, sickle cell trait884IncidenceH/A or L/A0.32 (0.09--1)No associationOlney et al. \[[@CR45]\]Zanzibar\<13 years (Follow-up of 6 months)*P. falciparum*Z-score (mean with SD) (WHO, 2006)RegressionNone247Incidence 5--9 monthsH/A0.008 (NS)No association247Incidence 10--14 monthsH/A−0.063 (NS)No associationMuhangi et al. \[[@CR46]\]UgandaBirth to 1 year (Follow-up of 1 year)*P. falciparum*Z-score (\<−2) (WHO, 2006)ORGender, number of living children in the family, early weaning, maternal age, maternal education, socio-economic status, low birth weight, HIV exposure1502IncidenceL/A2.12 (1.38-3.27)Risk1502IncidenceW/LNI (NS)No association1502IncidenceW/ANI (NS)No associationPadonou et al. \[[@CR47]\]BeninBirth to 18 months (Follow-up of 18 months)*P. falciparum*Z-score (WHO, 2006)CoefficientBirth place, mother's age, maternal short stature and low weight status, parity, number of pre-natal visits, marital status, mother's education, bed net protection, household wealth score, birth weight and length, gender, gestational age, prematurity, intra-uterine growth retardation, maternal anemia, placental malaria infection, use of intermittent preventive treatment520IncidenceH/A−0.03(0.02) (*p* = 0.15)No association520IncidenceW/H−0.01 (0.02) (*p* = 0.74)No associationAlexandre et al. \[[@CR39]\]Brazil1 month to 14 years (Follow-up of 12 months)*P. vivax* (72.6 %)/*P. falciparum* (22.5 %)/Mixed malaria *P.vivax* + *P. falciparum* (4.9 %)Cm/year (WHO, 2006; WHO, 2007)ORAge, gender, maternal education, socioeconomic status39Incidence≤5 years Increment on height1.1 (0.2--6.4)No association108Incidence5--10 years Increment on height4.0 (1.4--11.4)Risk55Incidence10--14 years Increment on height1.1 (0.2--4.8)No association39IncidenceZ-score (\<−2) ≤5 years H/A6.9 (0.3--161.6)No associationZ-score (\<−2) (WHO, 2006; WHO, 2007) 5--10 years108IncidenceH/A0.9 (0.3--3.1)No association108IncidenceW/A5.1 (0.5--45.9)No association108IncidenceBMI/A4.2 (0.4--39.1)No associationZ-score (\<−2) (WHO, 2006; WHO, 2007) 10--14 years55IncidenceH/A0.4 (0.1--2.2)No association55IncidenceBMI/A1.0 (0.1--17.0)No association*BMI* body mass index, *H/A* height/age, *W/H* weight/height, *W/A* weight/age, *AC/A* arm circumference/age, *L/A* length/age, *SD* standard-deviation, *NS* non-significant

Malnutrition as exposure for malaria {#Sec9}
------------------------------------

Twenty studies with malaria-related outcomes were included, twelve evaluating incidence, seven mortality and six parasitaemia. Five studies evaluated more than one type of outcome.

### Anthropometric parameters {#Sec10}

The most assessed anthropometric measures were W/A, with 25 evaluations from 14 studies, and H/A, with 27 evaluations from 11 studies. The W/H measure was obtained in 24 evaluations from 10 studies. The measure AC/A was obtained in four evaluations from two studies. All the other measures (AC, weight increment, W/A increment, H/A increment, W/A increment, AC/A increment and a combined index from H/A + L/A + W/H + W/A measures) were obtained in two evaluations from one study each. Thus, a total of 92 different anthropometric measures were obtained from the 20 studies, being 14 using National Center Health Statistics 1977 \[[@CR25]\], four the World Health Organization 2006 (WHO 2006) \[[@CR26]\] and one the WHO 2007 \[[@CR27]\] as standards. One study used weight increment (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Distribution by country of the assessments from the studies on malnutrition as exposure to malaria retrieved in this systematic review, including the type of outcome and association found. *Colors* indicate the type of association: *Red* risk, *Yellow* absence of association, *Green* protection

### Malaria incidence {#Sec11}

The impact of malnutrition on malaria incidence was assessed in 50 statistical comparisons from 12 studies, on parasite density in 25 comparisons from six studies and on mortality in 17 comparisons from seven studies (Table [2](#Tab2){ref-type="table"}). Of the 50 comparisons between malnutrition and malaria incidence, 37 evaluated clinical malaria in general, four evaluated specifically asymptomatic malaria, four evaluated *Plasmodium falciparum* malaria, two evaluated *Plasmodium vivax* malaria, two evaluated *Plasmodium malariae* malaria and one evaluated specifically non-severe malaria. Most of the evaluations failed to show any association between malnutrition and malaria incidence; 45/50 (90 %). However, three evaluations showed a risk association between malnutrition and malaria incidence in children: (1) underweight on *P. vivax* incidence in children above 10 years with undisclosed follow-up time \[[@CR30]\]; (2) AC/A on *P. falciparum* incidence in children under 9 months years with 3 months of follow-up \[[@CR32]\]; (3) Stunting on *P. falciparum* incidence in children between 0 and 5 years with 20 weeks of follow-up \[[@CR33]\]. Two evaluations showed a protective association: (1) Stunting on malaria incidence in children between 12 and 70 months with 25 weeks of follow-up \[[@CR17]\]; (2) stunting on *P. vivax* incidence in children up to 14 years with 1 year of follow-up \[[@CR38]\].

### Parasite density {#Sec12}

The 25 assessments of the relationship between malnutrition and malaria parasite density were highly heterogeneous: ten evaluated high parasite density (≥5000 parasites/mL), three evaluated high parasite density as ≥10,000 parasites/mL, three evaluated high parasite density as ≥5000 parasites/mL in asymptomatic malaria, three evaluated high parasite density as ≥300 parasites/mL, three evaluated high parasite density as ≥5000 parasites/mL specifically in *P. falciparum* malaria, three evaluated high parasite density as ≥10,000 parasites/mL specifically in *P. falciparum* malaria, one evaluated time to peak parasitaemia and one evaluated time to peak gametocytaemia.

Although the majority of studies showed no association between malnutrition and parasite density 20/25 (80 %); two evaluations showed a risk association: (1) Weight increments on time to peak *P.falciparum* parasite density in children of undisclosed age and 28 days of follow-up \[[@CR28]\]; (2) Stunting on *P.falciparum* parasite density above 300/µL in children above 5 years with 25 weeks of follow-up \[[@CR17]\]; while three comparisons showed a protective association: (1) weight increments on time to peak *P.falciparum* gametocytaemia in children of undisclosed age and 28 days of follow-up \[[@CR28]\]; (2) Stunting on *P.falciparum* parasite density of above 5000/µL in children above 5 years with undisclosed follow-up time \[[@CR16]\] and (3) Stunting on *P.falciparum* parasite density of above 5000/µL in children between 0 and 5 years with 1 year of follow-up \[[@CR15]\].

### Mortality and severity {#Sec13}

Of the 17 comparisons between malnutrition and mortality, three evaluated malaria, two focused on severe malaria, one in cerebral malaria, and one evaluated three forms: malaria, cerebral and malarial anaemia. There were 10/17 (52.8 %) evaluations with no association between malnutrition and mortality. Seven assessments showed a risk association between malnutrition and mortality in children: (1) underweight on falciparum clinical, cerebral and malarial anaemia in children between 0 and 5 years with undisclosed follow-up time \[[@CR2]\]; (2) underweight on falciparum mortality in children 1--7 months and between 8 months and 4 years with 1 year of follow-up \[[@CR31]\]; (3) underweight on falciparum death or recover with neurological deficit on cerebral malaria in children between 1 and 5 years with undisclosed follow-up time \[[@CR7]\]; (4) wasting on falciparum severe malaria in children above 5 years with undisclosed follow-up time \[[@CR35]\].

Malaria as exposure for malnutrition {#Sec14}
------------------------------------

Thirteen studies assessed the impact of malaria in nutrition, of them 10 assessed the role of malaria incidence (yes/no) while the remaining three used parasite density as the exposure of interest. The impact of malnutrition on malaria incidence was measured in 39 assessments from 10 studies and on parasite density in six assessments from three studies (Table [3](#Tab3){ref-type="table"}; Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Distribution by country of the assessments from the studies on malaria as exposure to malnutrition retrieved in this systematic review, including the type of exposure and association found. *Colors* indicate the type of association: *Red* risk, *Yellow* absence of association, *Green* protection

### Anthropometric parameters {#Sec15}

The most frequently assessed anthropometric measures were H/A, or L/A with 15 evaluations from nine studies, and W/H or W/L with eight evaluations from six studies. The W/A measure was obtained in seven evaluations from six studies. The measure BMI/A was obtained in five evaluations from two studies and so were height increments. The measure of BMI was evaluated two times in one study and the weight increment and fall in weight were obtained once. Thus, a total of 45 different anthropometric measures were obtained from the 13 studies, being four using NCHS, 1977 \[[@CR25]\], five the WHO 2006 \[[@CR26]\], one using CDC/NCHS (2000) \[[@CR48]\] and one the WHO 2007 \[[@CR27]\] as standards. Two studies used weight and/or height change.

Most such evaluations did not show an association between malaria and malnutrition 31/39 (79.4 %). Eight showed a risk association between malaria and subsequent malnutrition in children: (1) incidence of unspecified malaria on increment in weight in children between 0 and 5 years with 1 year of follow-up \[[@CR40]\]; (2) Incidence of vivax malaria on W/H in children above 5 years with undisclosed follow-up time \[[@CR30]\]; (3) incidence of falciparum malaria on H/A in children between 28 and 60 months with 1 year and 5 months of follow-up \[[@CR36]\]; (4) incidence of unspecified malaria on H/A or L/A in children between 3 months to 2 years with 1 year and 9 months of follow-up \[[@CR37]\]; (5) incidence of falciparum malaria on L/A and W/A in children from birth to 1 year with 1 year of follow-up \[[@CR46]\]; (6) incidence of vivax/falciparum malaria on increment in height in children 5--10 years and 0--14 years with 1 year of follow-up \[[@CR39]\].

Two out of six (20 %) assessments showed a positive association between parasite density and malnutrition in children: (1) mean falciparum/mixed malaria parasite density on H/A in children 6--9 months and 14--20 months with 1 year and 9 months of follow-up \[[@CR41]\]; (2) mean falciparum parasite density on BMI in children above 5 years with undisclosed follow-up time \[[@CR42]\].

Methodological quality of studies {#Sec16}
---------------------------------

Of the 20 studies with malarial outcomes, fifteen had high and five had average quality according to the questionnaire of 12 items, with an average score of 80.5 %. The main methodological problem in these studies was not describing the main outcome measures (diagnostic technique for malaria and nutritional status). Of the fifteen high-quality studies, eight presented a risk association. Of the five medium quality, one found a risk association, totaling nine studies that found malnutrition as a risk factor for malaria (four in incidence, four mortality, and one in parasite density) (Tables [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"}).Table 4Methodological quality of the longitudinal studies on anthropometric measures as exposures with malaria-related outcomesIdentificationQuestion123456789101112Score (%)Pazzaglia et al. \[[@CR28]\]YYNYNYNYNNYY58.3Snow et al. \[[@CR29]\]YNNYYNNYYN--Y54.5Van den Broeck et al. \[[@CR21]\]YNNNYNYYYYNY58.3Genton et al. \[[@CR22]\]YYYYYYYYYN--Y90.9Olumese et al. \[[@CR7]\]YYNYYYNYYNYY75.0Renaudin et al. \[[@CR20]\]YNYYNNYYYNNY58.3Williams et al. \[[@CR30]\]YYYYYNNYYY--Y82.8Man et al. \[[@CR2]\]YYNYYNNYYNNY58.3Genton et al. \[[@CR16]\]YYYYYYNYYYYY91.6Schellenberg et al. \[[@CR31]\]YYYYYNYYYYYY91.6Tonglet et al. \[[@CR32]\]YNNYYYYYYNYY75.0Deen et al. \[[@CR33]\]YNYYYYYYYYYY91.6Müller et al. \[[@CR34]\]YYYYYYNYYYYY91.6Mockenhaupt et al. \[[@CR35]\]YYYYYYYYYNYY91.6Nyakeriga et al. \[[@CR36]\]YYYYYYNYYYYY91.6Danquah et al. \[[@CR37]\]YNNYYYYYYNYY75.0Fillol et al. \[[@CR17]\]YYYYYYYYYYYY100.0Arinaitwe et al. \[[@CR38]\]YNYYYYYYYYYY91.6Mitangala et al. \[[@CR15]\]YYYYYYYYYYYY100.0Alexandre et al. \[[@CR39]\]YYYYNYYYYYNY83.3(--) not informedTable 5Methodological quality of the longitudinal studies with malaria-related exposures and nutritional-related outcomesIdentification**Question**123456789101112Score (%)Rowland et al. \[[@CR40]\]YNNYYNNYYY-Y63.6Williams et al. \[[@CR30]\]YYYYYNNYYY-Y81.8Hautvast et al. \[[@CR41]\]YYYYYYYYYYYY100.0Deen et al. \[[@CR33]\]YNYYYYYYYYYY91.6Friedman et al. \[[@CR42]\]YNYYYYYYYYYY91.6Nyakeriga et al. \[[@CR36]\]YYYYYYNYYYYY91.6Sowumi et al. \[[@CR43]\]YYYYYYNYYYYY91.6Danquah et al. \[[@CR37]\]YNNYYYYYYNYY75.0Kang et al. \[[@CR44]\]YNYYYNNYYYYY75.0Olney et al. \[[@CR45]\]YNNYNNYYYYYY66.6Muhangi et al. \[[@CR46]\]YYYYYYYYYY-Y90.9Padonou et al. \[[@CR47]\]YYYYYYYYYYYY100.0Alexandre et al. \[[@CR39]\]YYYYNYYYYYNY83.3(-) not informed

Of the 13 studies assessing nutritional status as the outcome, eleven had high and two medium quality according to the questionnaire of 12 items, with a mean score of 84.8 %. The main methodological problem in these studies was not clearly describing the exposure and the outcome (malaria species or anthropometric indicators with their anthropometric references). Of the eleven high quality studies, six had positive associations. Of the two medium quality, one found a positive association, totaling seven studies that found malaria as risk factor for malnutrition (5 using malaria incidence and 2 using parasite density).

Discussion {#Sec17}
==========

Previous studies on the association of malaria and malnutrition delivered inconsistent results. These conflicting results could be explained by different levels of confounding and to considerable methodological dissimilarities. Randomized controlled trials are impractical and previous observational studies have not fully controlled for potential confounding including nutritional deficiencies, breastfeeding habits, other infectious diseases and socioeconomic status \[[@CR46]\]. For the purpose of this systematic review, we restricted the nutritional assessment metrics to the above listed anthropometric measures as these have shown to be strong, reproducible indicators \[[@CR49]\]. A significant heterogeneity in the assessed studies was observed in terms of sample size, follow-up time, exposure and outcome definitions, thus impeding a metanalysis, but in general the methodological quality of the retrieved studies was good enough to generate important conclusions. Here, results from longitudinal studies were emphasized, thus allowing temporal definitions, but quality of anthropometric measurements and their comparability across studies may constitute limitations.

The majority of studies showed no association between malnutrition and subsequent malaria incidence or parasite density. One study suggested a protective effect against malaria for malnutrition diagnosed by W/A \[[@CR17]\]. In contrast, other studies have found an increased risk of malaria among stunted and underweight children \[[@CR30], [@CR32], [@CR33], [@CR38]\]. Earlier studies showed the presence of malaria in famine victims within few days of re-feeding and suggested that feeding provided essential nutrients for sequestered parasites leading to recrudescent infection \[[@CR50], [@CR51]\]. Whether other nutritional parameters are involved in the pathophysiology of nutrition and malaria is still controversial. The role of vitamin A, iron, zinc and other micronutrients in malaria is still a topic of debate \[[@CR52]\]. In monkeys and mice, a low-protein diet was associated to a lower parasitaemia \[[@CR53]--[@CR55]\]. Most works found greater effects in younger age groups \[[@CR17], [@CR32], [@CR36]\].

Measuring the association between measures of malnutrition and the risk of malaria is complex and is hampered by the multiplicity of metrics used for malnutrition. Stunting is generally considered an indicator of chronic malnutrition, wasting generally reflects a more recent and severe process, and being underweight is likely the result of both factors \[[@CR38]\]. The results presented in this review support that malnutrition has not a great impact on malaria incidence and parasitaemia, although in a few epidemiological scenarios stunting, underweight and decreased increment on weight over time were measures of chronic malnutrition associated with an increased risk of malaria or high parasite density. Children who are underweight likely have increased susceptibility to malaria, most notably through a reduction in the function of the immune system \[[@CR56]\]. An undernourished child is unable to mount an appropriate immune response to the malaria parasite due to reduction in T lymphocytes, impairment of antibody formation, decreased complement formation and atrophy of lymphoid tissues \[[@CR1], [@CR17]\]. Monkeys maintained on a low-protein diet were unable to clear the infection, resulting in multiple recrudescences \[[@CR53]\]. Immune responses were also suppressed and parasitaemia appeared earlier and lasted longer in non-human primates \[[@CR57]\].

The impact of malnutrition was noted mostly in malaria mortality and severity. Death or recovery with a neurological deficit on cerebral malaria was significantly associated with malnutrition in Nigerian children \[[@CR7]\]. Underweight was identified as a risk factor for mortality, cerebral malaria and malarial anaemia in Gambian children \[[@CR2]\] and with mortality in Tanzanian children, mostly in younger age groups \[[@CR31]\]. Wasting was associated to mortality in children above 5 years in Ghana \[[@CR35]\]. Some series of cases showed that cerebral malaria was more prevalent in well-nourished children than in children with severe malnutrition including kwashiorkor or marasmus \[[@CR12], [@CR13], [@CR58]\]. In this study, cohort studies that evaluated mortality and other adverse malaria outcomes show risk of severe malnutrition \[[@CR2], [@CR7], [@CR31], [@CR35]\]. As shown previously, anthropometric measurements are consistently related to the risk of outcomes such as mortality in community-based studies from Asia and Africa \[[@CR59]\]. In mice, it was noted an increased lethality in severely malnourished animals \[[@CR60]\]. Although information on sensitive treatment surveillance was generally absent in the studies, it use some locations would be biased toward detecting differences in the onset of a malaria episode and not necessarily the subsequent severity. In malnutrition as exposure to malaria morbidity, studies that found protective associations had at least 1 year of follow-up whereas studies with risk associations only followed for 6 months or less. Most of the associations were found for height/age index, a marker of stunting or chronic malnutrition.

Anthropometric interaction of malaria and nutrition is confounded by micronutrient status, which also impacts on malaria severity \[[@CR61]\], but unfortunately this potential bias was approached only in one study. The inability of anthopometry to distinguish the effect of specific nutrient deficiencies that affect growth in children is another limitation of this method \[[@CR62]\]. Only five studies controlled for malaria treatment exposure \[[@CR17], [@CR22], [@CR38], [@CR44], [@CR47]\] and four controlled for vector control measures \[[@CR15], [@CR16], [@CR34], [@CR47]\]. Prevention of malaria by intermittent preventive treatment was found to improve weight status in children \[[@CR42], [@CR63]\]. If malaria-specific interventions are responsible for this accelerated linear growth rate, the most likely explanation is that early treatment of clinical malaria prevented prolonged carriage of *P. falciparum* and its associated growth-depressing immune response \[[@CR63]\]. Thus, a bias can be present in studies without this control. Different anthropometric assessment methods from studies with small sample sizes limited the comparability between findings retrieved in this study. It is known that WHO standards provide a better tool to monitor the rapid and changing rate of growth in early infancy \[[@CR64]\]. Results from the retrieved studies were controlled for socioeconomic factors in a few cases, increasing the possibility of confounding \[[@CR49]\].

*Plasmodium vivax* infection has been associated with severe malaria and death \[[@CR65]\], although the risk of severe vivax malaria and case fatality rates are not well defined \[[@CR66]\]. Co-morbidities are considered important contributors to severe complications of *P. vivax* infection. In particular, concomitant malnutrition is suspected to increase the risk of severe vivax disease, but this is not well understood. The demographic risk of severe vivax malaria in regions of relatively high endemicity is skewed towards early infancy (a stage when severe anaemia is a major cause of morbidity). A clearer picture of severe vivax malaria is emerging, but further studies are required to refine existing knowledge of the spectrum of syndromes and its association with malnutrition \[[@CR39]\].

The relative insensitivity of anthropometry to detect changes in nutritional status over short periods of time limited conclusions from studies of short follow-ups. One speculates that hypercatabolism and inflammatory status induced by malaria may have an effect on nutritional well-being. TNF is a known mediator of anorexia and cachexia seen in many human disease states and is elevated during acute malaria \[[@CR67]--[@CR69]\]. In this systematic review, most of the studies showed no association between malaria incidence and malnutrition. As most anthropometric measures used gauged chronic malnutrition, one could speculate that if malaria has an effect on nutritional status, it would have be assessed with metrics targeting acute malnutrition. In areas where malaria is hyper-endemic, repeated infections throughout life may contribute to the burden of malnutrition, specially in children \[[@CR36], [@CR37], [@CR40], [@CR46]\]. No risk associations were found for malaria as exposure to malnutrition in studies with less than 1 year of follow-up.

Interestingly, in Vanuatu and in the Brazilian Amazon, where *P. vivax* contributes with a great percentage of the malaria cases, malaria has been associated with malnutrition in children \[[@CR30], [@CR39]\]. In these areas there is a general consensus stating that *P. vivax* would not be associated with malnutrition due to the misleading information that vivax malaria is benign \[[@CR66]\]. However, this parasite species is able to develop dormant stages (hypnozoites) in the liver leading to frequent relapses, even months after the primary infection \[[@CR70]\]. One especulates that this chronic relapsing nature of *P. vivax* may lead to a degree of chronic inflammation. Whether relapsing malaria significantly impairs nutritional status in *P. vivax* affected areas warrants further research.

Conclusion {#Sec18}
==========

In conclusion, this systematic review found that the majority of studies assessing malaria and malnutrition were carried out in African *P. falciparum* endemic areas, with a significant study heterogeneity in terms of sample size, follow-up time and exposure and outcome definitions. Considering malnutrition as exposure, the results presented in this review support that malnutrition has not a great impact on malaria incidence and parasitaemia, but a greater negative impact of malnutrition was noted in malaria mortality and severity. A scarcity of prospective studies have been carried out aiming to establish the relationship between nutritional status and severity of vivax infection, this being a prioritary research topic. Most of the assessed studies showed no association between malaria incidence and malnutrition in areas of *P. falciparum* predominance, although the anthropometric parameters used were aimed mostly at chronic malnutrition, possibly suggesting that the impact of malaria on nutritional status may be of little significance in the long term. Interestingly, in areas where *P. vivax* contributes with a great percentage of the cases, malaria was associated with risk for malnutrition in children. A discussion among experts in the field is needed to standardize the observational studies considering external validity in order to allow for more accurate conclusions.
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